Sitemap
November 22, 2021 Articles
Filter by Available Specialty
- ‘Treat-to-target is key’: Allopurinol noninferior to febuxostat for gout when properly dosed
- 18% of US adults with hypertension take medications that may raise BP
- ACG updates guidelines for GERD diagnosis, management
- AI-guided arrhythmia diagnostic tool nets FDA clearance for use in pediatric cardiology
- Allergist-school partnership enables asthma treatment without grant money
- Alternative medicine use common among patients with hidradenitis suppurativa
- Alvesco no better than placebo for alleviating COVID-19 symptoms
- APA calls for action to address high number of overdose deaths
- Bimekizumab shows early efficacy in psoriatic arthritis
- Bisphosphonate therapy may prevent fracture in postmenopausal women with osteoporosis
- CGM as medicine: Technology benefits extend to type 2 diabetes
- Clinical factors not necessary exclusion criteria for deep brain stimulation in OCD
- COVID-19 vaccine booster benefits ‘outweigh risks’ among immunocompromised
- Cystic fibrosis therapies changing landscape of nutrition, cardiometabolic health
- Despite progress, certain populations remain underrepresented in cancer clinical trials
- Do the benefits of CGM justify the current cost in type 2 diabetes care?
- Epithelial mapping key to keratoconus screening, therapeutic surgery
- FDA approves device for treatment of advanced PD
- FDA grants orphan drug designation to toripalimab for esophageal cancer
- FDA grants priority review to betibeglogene autotemcel for beta-thalassemia
- Fear of side effects, rheumatic disease flare top reasons for COVID-19 vaccine hesitancy
- Gout significantly affects patients with advanced CKD
- In current smokers, first CV event could be fatal
- Low skeletal muscle mass, grip strength linked to CVD risk in type 2 diabetes
- Mental health training for clinicians reduces stigma, improves diagnostic accuracy
- Multidisciplinary care key in updated pheochromocytoma, paraganglioma guideline
- New ATS guideline addresses use of FeNO to guide asthma treatment
- Patient-reported outcomes beyond 1 year may be unnecessary for accurate TKA assessment
- Pegloticase seen as safe and effective for uncontrolled gout in kidney transplant patients
- Possible explanation for yellow fever's return in Brazil: Drought
- Potassium, phosphorus levels are not definitive judgements for dialysis adherence
- Quizartinib regimen extends OS for certain patients with acute myeloid leukemia
- Rubber bullets carry high risk for blindness, eye loss when used at protests
- Saghmos to launch phase 3 study with patent for ST-62516, trimetazidine
- Smartphone app may help detect concussions
- Staph remains leading SSTI, expert says
- Stress level up, mood and physical activity down during COVID-19 lockdown
- Technology-assisted TKA may yield lower 90-day readmission rates
- To boost or not to boost: That is the question
- Top in cardiology: Highlights from American Heart Association Scientific Sessions
- VIDEO: Aurion Biotech discusses keys to treating patients with corneal endothelial disease
- VIDEO: Data show MIGS procedures to be effective, safe
- VIDEO: Immunosuppressives may negate anti-drug antibody development from pegloticase
- VIDEO: Obeticholic acid improves survival in primary biliary cholangitis
- VIDEO: Prevalence of gout high in patients on dialysis